The standard of care is standard for a reason: Commentary on "Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients: A systematic review and Meta-analysis of randomized clinical trials"
- PMID: 37244208
- PMCID: PMC10209671
- DOI: 10.1016/j.jcrc.2023.154345
The standard of care is standard for a reason: Commentary on "Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients: A systematic review and Meta-analysis of randomized clinical trials"
Keywords: Anticoagulants; COVID-19; Coagulation; Critical illness; Drug dosing.
Conflict of interest statement
Declaration of Competing Interest None of the authors have financial or intellectual conflicts of interest to disclose regarding this topic or material.
Comment on
-
Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients a systematic review and meta-analysis of randomized controlled trials.J Crit Care. 2023 Oct;77:154344. doi: 10.1016/j.jcrc.2023.154344. Epub 2023 May 25. J Crit Care. 2023. PMID: 37244209 Free PMC article.
References
-
- Cuker A., Tseng E.K., Nieuwlaat R., Angchaisuksiri P., Blair C., Dane K., et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. Blood Adv. 2022;6(2):664–671. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical